Antidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: In vivo approach

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 230-236

  Amalan, Venkatesan ^a   Vijayakumar, Natesan ^a   Indumathi, Dhananjayan ^a   Ramakrishnan, Arumugam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Carbohydrate metabolic enzyme; Diabetes mellitus; GLUT 2; Lipid; p Coumaric acid; Streptozotocin

Indexed keywords

CHOLESTEROL; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 2; GLUTATHIONE; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OXIDOREDUCTASE; PARA COUMARIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; 4-COUMARIC ACID; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; COUMARIC ACID; GLUCOSE BLOOD LEVEL; LIPID; SLC2A2 PROTEIN, RAT; STREPTOZOCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DRUG DOSE COMPARISON; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DOWN REGULATION; DRUG EFFECTS; GENETICS; KIDNEY; LIVER; METABOLISM; PANCREAS; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; COUMARIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 2; GLUTATHIONE; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; KIDNEY; LIPIDS; LIVER; MALE; PANCREAS; RATS, WISTAR; RNA, MESSENGER; STREPTOZOCIN;

EID: 84988369443     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.09.039     Document Type: Article

References (47)

1. [1] International Diabetes Federation, IDF Diabetes ATLAS. sixth edition, 2014.
2. [2] Saddala, R.R., Thopireddy, T., Ganapathi, N., Kesireddy, S.R., Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin induced diabetic rats treated with aqueous extract of pimpinella tirupatiensis tuberous root. Exp. Toxicol. Pathol. 65 (2013), 15–19.
3. [3] Kim, S.K., Wijesekara, I., Development and biological activities of marine-derived bioactive peptides: a review. J. Funct. Foods 1 (2010), 1–9.
4. [4] Sesti, G., Phathophysiology of insulin resistance. Best. Pract. Res. Clin. Endocrinol. Metab. 20 (2006), 665–679.
5. [5] Chakraborty, U., Das, H., Antidiabetic and antioxidant activities of Cinnamomum tamala leaf extracts in stz-treated diabetic rats. GJBB 5 (2010), 12–18.
6. [6] Visweswara Rao, P., Dhananjaya Naidu, M., Anti-diabetic effect of rhinacanthus nasutus leaf extract in streptozotocin induced diabetic rats. IJASR 5 (2010), 310–312.
7. [7] Sundaram, M.L., Philip, E., Das, R., Chauhan, S.K., Deshpande, S., Ambhore, S., Rathod, R., Manjrekar, P., Acarbose improves glycemic control ass add on or monotherapy in Indian type-2 diabetes: finding from the Gluco VI P multinational observational study. Indian J. Endoccrinol. Metab. 17 (2013), 674–679.
8. [8] Sivakumar, S., Subramanian, S.P., D-pinitol attenuates the impaired activites of hepatic enzymes in carbohydrates metabolism of steptozocin induced diabetic rats. Gen. Physiol. Biophys. 28 (2009), 233–241.
9. [9] Sellamuthu, P.S., Arulselvan, P., Fakurazi, S., Kandasamy, M., Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes. Pak. J. Pharm. Sci. 27 (2014), 161–167.
10. [10] Kulkarni, C.R., Joglekar, M.M., Patil, S.B., Arvindekar, A.U., Antihyperglycemic and antihyperlipidemic effect of Santalum album in streptozotocin induced diabetic rats. Pharm. Biol. 50 (2012), 360–365.
11. [11] Betteridge, D.J., LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM. Diabetologia 40 (1997), 149–151.
12. [12] Marinangeli, C.P., Varady, K.A., Jones, P.J., Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action. J. Nutr. Biochem. 17 (2006), 217–224.
13. [13] Prabakaran, D., Ashokkumar, N., Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats. Biochimie 95 (2013), 366–373.
14. [14] Huang, S.S., Chiu, C.S., Chen, H.J., Hou, W.C., Sheu, M.J., Lin, Y.C., Shie, P.H., Huang, G.J., Antinociceptive activities and the mechanisms of anti-inflammation of asiatic acid in mice. CAM, 2011, 1–10.
15. [15] Yoon, S.A., Kang, S.I., Shin, H.S., Kang, S.W., Kim, J.H., Kim, S.J., p-Coumaric acid modulates glucose and lipid metabolism via AMP-activated protein kinase in L6 skeletal muscle cells. Biochem. Biophys. Res. Commun. 22 (2013), 553–557.
16. [16] Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols. J. Nutr. 130 (2000), 2073–2085.
17. [17] Abdel-Wahab, M.H., El-Mahdy, M.A., Abd-Ellah, M.F., Helal, G.K., Khalifa, F., Hamada, F.M.V., Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat's heart. Pharmacol. Res. 48 (2003), 461–465.
18. [18] Punithavathi, V.R., Prince, P.S.M., Ramesh Kumar, A., Selvakumari, J., Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur. J. Pharmacol. 650 (2011), 465–471.
19. [19] Vetrikumaran, K., Pari, L., Rajasekaran, M., Palani, S., Protective effect of P-coumaric acid against alcohol induced biochemical changes in rats. Research. J. Biol. Sci. 3 (2011), 8–17.
20. [20] Vauzour, D., Corona, G., Spencer, J.P., Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch. Biochem. Biophys. 501 (2010), 106–111.
21. [21] Amalan, V., Vijayakumar, N., Antihyperglycemic effect of p-Coumaric acid on streptozotocin induced diabetic rats. IJAR 5 (2015), 10–13.
22. [22] Amalan, V., Vijayakumar, N., Ramakrishnan, A., p-Coumaric acid regulates blood glucose and antioxidant levels in streptozotocin induced diabetic rats. J. Chem. Pharm. Res. 7 (2015), 831–839.
23. [23] Murali, R., Srinivasan, S., Ashokkumar, N., Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Biochimie 95 (2013), 1848–1854.
24. [24] Trinder, P., Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6 (1969), 24–27.
25. [25] Brandstrup, N., Kirk, J.K., Bruni, C., Determination of hexokinase in tissues. J. Gerontol. 12 (1957), 166–171.
26. [26] Ellis, H.A., Kirkman, H.N., A colorimetric method for assay of erythrocyte glucose-6-phosphate dehydrogenase. Proc. Soc. Exp. Biol. Med. 106 (1961), 607–609.
27. [27] Gancedo, J.M., Gancedo, C., Fructose-1,6-bisphosphatase, phospho fructokinase and gluctose-6-phosphatase dehydrogenase from fermenting and non-fermenting yeasts. Arch. Microbiol. 76 (1971), 132–138.
28. [28] Ellman, G.L., Tissue sulphydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
29. [29] Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., Fu, P.C., Enzymatic determination of total serum cholesterol. Clin. Chem. 20 (1974), 470–475.
30. [30] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972), 499–502.
31. [31] McGowan, M.W., Artiss, J.D., Strandbergh, D.R., Zak, B., A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29 (1983), 538–542.
32. [32] Duncan, B.D., Multiple range tests for correlated and heteroscedastic means. Biometrics 13 (1957), 359–364.
33. [33] Irudayaraj, S.S., Sunil, C., Duraipandian, V., Ignacimuthu, S., Antidiabetic and antioxidant activities of Toddalia asiatica (L.) Lam. leaves in streptozotocin induced diabetic rats. J.Ethnopharmacol 143 (2012), 515–523.
34. [34] Laakso, M., Malkki, M., Deeb, S.S., Aminoacid substituents in hexokinase II among patients with NIDDM. Diabetes 44 (1995), 330–334.
35. [35] Shulman, R., Miller, F.A., Stukel, T.A., Daneman, D., Guttmann, A., Resources and population served: a description of the ontario paediatric diabetes network. CMAJ Open. 19 (2016), 141–146.
36. [36] Pari, L., Murugan, P., Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J. Basic Clin. Physiol. Pharmacol. 16 (2005), 257–274.
37. [37] Halliwall, B., Gutteridge, J.M.C., Lipid peroxidation oxygen radicals, cell damage and antioxidant therapy. Lancet 1 (1994), 1396–1397.
38. [38] Levine, W.G., Interaction of ascorbic acid and α-tocopherol. Ann. Nutr. Acad. Sci. 498 (1990), 186–199.
39. [39] Shew, W.H., Jeng, C.Y., Lee, W.J., Lin, S.Y., Pei, D., Chen, Y.T., Simvastatin treatment in postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia. Metabolism 50 (2001), 355–359.
40. [40] Pushparaj, P., Tan, C.H., Tan, B.K., Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J. Ethnopharmacol. 72 (2000), 69–76.
41. [41] Zang, L.Y., Cosma, G., Gardner, H., Shi, X., Castranavo, V., Vallynathan, V., Effect of antioxidant protection by p-Coumaric acid on low-density lipoprotein cholesterol oxidation. Am. J. physiol. Cell. physiol. 279 (2000), 954–960.
42. [42] Sambandam, N., Abrahani, M.A., Craig, S., Al-Atar, O., Jeon, E., Rodrigues, B., Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am. J. Physiol. Heart Circ. Physiol. 278 (2000), 1874–1882.
43. [43] Mueckler, M., Thorens, B., The SLC2 (GLUT) family of membrane transporters. Mol. Aspects Med. 34 (2013), 121–138.
44. [44] Kellett, G.L., Brot-Laroche, E., Mace, O.J., A leturque, Sugar absorption in the intestine: the role of GLUT-2. Annu. Rev. Nutr. 28 (2008), 35–54.
45. [45] Schuit, F., Flamez, D., Vos, A.D., Pipeleers, D., Glucose-regulated gene expression maintaining the glucose-responsive state of β-cells. Diabetes 51 (2002), 326–332.
46. [46] Burkhardt, B.R., Parker, M.J., Zhang, Y.C., Wasserfall, C.H., Atkinson, M.A., Glucose transporter-2 promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS 579 (2005), 5759–5764.
47. [47] Kanitkar, M., Gokhale, K., Galande, S., Bhonde, R.R., Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. Br. J. Pharmacol. 155 (2008), 702–713.